Phillip A. Sharp - May 23, 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Role
Director
Signature
/s/ Howard Horn, Attorney-in-Fact
Stock symbol
VIR
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4
Date filed
5/25/2022, 06:12 PM
Previous filing
May 20, 2022
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VIR Common Stock Award $0 +6.41K +5.89% $0.00 115K May 23, 2022 Direct
holding VIR Common Stock 44.4K May 23, 2022 See footnote F1
holding VIR Common Stock 44.4K May 23, 2022 See footnote F2
holding VIR Common Stock 44.4K May 23, 2022 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VIR Stock Option (Right to Buy) Award $0 +12.8K $0.00 12.8K May 23, 2022 Common Stock 12.8K $24.14 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Sarah Brokaw, over which the reporting person's spouse is co-trustee.
F2 The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Helena Sharp, over which the reporting person's spouse is co-trustee.
F3 The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Christine Carey, over which the reporting person's spouse is co-trustee.